Diagnostik unterfinanziert, zugelassene Testallergene fehlen

Zurück zum Zitat Li Y, Minhas JS, Blumenthal KG: Economic impact of Drug Allergy. In: D. Khan, A. Banerji (Herausg.): Drug Allergy Testing. Elsevier, St. Louis, 2018; pp.11–18CrossRef Li Y, Minhas JS, Blumenthal KG: Economic impact of Drug Allergy. In: D. Khan, A. Banerji (Herausg.): Drug Allergy Testing. Elsevier, St. Louis, 2018; pp.11–18CrossRef

Zurück zum Zitat Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 2015;24:94–105CrossRefPubMedPubMedCentral Brockow K, Przybilla B, Aberer W, Bircher AJ, Brehler R, Dickel H, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (OGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). Allergo J Int 2015;24:94–105CrossRefPubMedPubMedCentral

Zurück zum Zitat Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA et al. International Consensus on drug allergy. Allergy 2014;69:420–37CrossRefPubMed Demoly P, Adkinson NF, Brockow K, Castells M, Chiriac AM, Greenberger PA et al. International Consensus on drug allergy. Allergy 2014;69:420–37CrossRefPubMed

Zurück zum Zitat Klimek L, Werfel T, Vogelberg C, Jung K. Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written. Allergo J Int 2015;24:84–93CrossRefPubMedPubMedCentral Klimek L, Werfel T, Vogelberg C, Jung K. Authorised allergen products for intracutaneous testing may no longer be available in Germany: Allergy textbooks have to be re-written. Allergo J Int 2015;24:84–93CrossRefPubMedPubMedCentral

Zurück zum Zitat Klimek L, Hoffmann HJ, Renz H, Demoly P, Werfel T, Matricardi PM, et al. Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective. Allergy 2015;70:1329–31CrossRefPubMed Klimek L, Hoffmann HJ, Renz H, Demoly P, Werfel T, Matricardi PM, et al. Diagnostic test allergens used for in vivo diagnosis of allergic diseases are at risk: a European Perspective. Allergy 2015;70:1329–31CrossRefPubMed